Valence8 Us LP Portfolio Holdings

Valence8 Us LP

$241 Billion
Q3 2024

Valence8 Us LP has filed its 13F form on November 12, 2024 for Q3 2024 where it was disclosed a total value porftolio of $241 Billion distributed in 62 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ishares Msci Usa Quality Facto with a value of $60.5B, Invesco Qqq Trust, Series 1 with a value of $43B, Ishares Msci Intl Quality Fact with a value of $42.6B, Msci Eafe Value ETF with a value of $23B, and Vanguard Value ETF with a value of $16.9B.

Examining the 13F form we can see an increase of $49.2B in the current position value, from $192B to 241B.

Valence8 Us LP is based out at Cambridge, MA

Below you can find more details about Valence8 Us LP portfolio as well as his latest detailed transactions.

Portfolio value $241 Billion

ETFs: $219 Billion

Healthcare: $19 Billion

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
ENTA Enanta Pharmaceuticals Inc Healthcare	$131M	$207 Million 0.09% of portfolio	19,939	Q3 2024 New
KMPH Kempharm, Inc Healthcare	$170M	$150 Million 0.06% of portfolio	21,596	Q3 2024 New
ALEC Alector, Inc. Healthcare	$163M	$68.5 Million 0.03% of portfolio	14,708	Q3 2024 New
ELYM Eliem Therapeutics, Inc. Healthcare	$109M	$61.3 Million 0.03% of portfolio	12,045	Q3 2024 New
NKTR Nektar Therapeutics Healthcare	$187M	$33.9 Million 0.01% of portfolio	26,107	Q3 2024 New

Summary

Portfolio
No. of Stocks 62
Current Value $241 Billion
Prior Value $192 Billion
Filing
Period Q3 2024
Filing Date November 12, 2024
Form Type 13F-HR
Activity in Q3 2024
New Purchases 31 stocks
Additional Purchases 3 stocks
Sold out of 0 stocks
Reduced holdings in 4 stocks

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Valence8 Us LP, based on Form 13F filings with the SEC.

News

Stay updated on Valence8 Us LP with notifications on news.

Account